Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan
Clicks: 107
ID: 273436
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.1
/100
7 views
7 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract. Pathological interplay between the heart and kidneys—also known as cardio-renal syndrome (CRS)—is frequently encountered in heart failure and is linke
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (23 words).
Try re-searching for a better abstract.
| Reference Key |
francesco2017europeanpharmacological
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Fedele, Francesco;Karason, Kristjan;Matskeplishvili, Simon; |
| Journal | European Heart Journal Supplements |
| Year | 2017 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.